Energy Drink Knowledge, Consumption, and Regulation Support Among Polish Medical and Non-Medical Students: A Cross-Sectional Study
Abstract
Background: Energy drink [ED] consumption is common among young adults and has been linked to adverse health effects and risky behaviors. This study compared medical and non-medical university students to assess whether health education influences knowledge, consumption, and attitudes toward EDs. Although medical and non-medical students are not minors, their opinions on the national ban on EDs sales to individuals under 18 provide valuable insight into attitudes toward regulation. Material and Methods: A cross-sectional online survey was conducted among 871 students (42.1% medical, 57.9% non-medical). The questionnaire assessed demographics, ED consumption, knowledge, motivations, and regulatory attitudes. It was pilot-tested on 30 students to ensure clarity, and internal consistency was confirmed (Cronbach’s α = 0.78 for knowledge; α = 0.81 for attitudes). Non-parametric tests (Mann–Whitney U, Kruskal–Wallis) and chi-square analyses compared groups. Results: Participants’ mean age was 22.1 years; most were female (73.2%). Medical students demonstrated significantly better knowledge of ED ingredients (simple sugars, B vitamins, L-carnitine, electrolytes; p < 0.01) and adverse effects (e.g., irritability, dizziness, nausea; p < 0.05). However, ED consumption frequency did not differ between medical and non-medical students. The main reasons for ED use were energy and concentration; social motives were less frequent. Female students more often supported the ban on ED sales to…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.